D. Sillence

661 total citations
22 papers, 451 citations indexed

About

D. Sillence is a scholar working on Genetics, Molecular Biology and Oncology. According to data from OpenAlex, D. Sillence has authored 22 papers receiving a total of 451 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Genetics, 10 papers in Molecular Biology and 6 papers in Oncology. Recurrent topics in D. Sillence's work include Connective tissue disorders research (12 papers), Bone health and treatments (4 papers) and Bone and Dental Protein Studies (4 papers). D. Sillence is often cited by papers focused on Connective tissue disorders research (12 papers), Bone health and treatments (4 papers) and Bone and Dental Protein Studies (4 papers). D. Sillence collaborates with scholars based in Australia, United States and New Zealand. D. Sillence's co-authors include David L. Rimoin, William A. Horton, K. Kozlowski, Judith G. Hall, Leonard O. Langer, Ralph Lachman, A. K. Poznanski, Peter Beighton, Robert J. Gorlin and P Maroteaux and has published in prestigious journals such as Radiology, Bone and Journal of Medical Genetics.

In The Last Decade

D. Sillence

22 papers receiving 433 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D. Sillence Australia 10 310 181 116 80 45 22 451
E H Zackai United States 7 213 0.7× 258 1.4× 87 0.8× 43 0.5× 9 0.2× 12 434
V. Stenszky Hungary 12 284 0.9× 61 0.3× 120 1.0× 35 0.4× 17 0.4× 33 678
Gail C. Jackson United Kingdom 10 194 0.6× 188 1.0× 162 1.4× 40 0.5× 99 2.2× 11 397
Hans J. van der Harten Netherlands 13 231 0.7× 235 1.3× 53 0.5× 98 1.2× 35 0.8× 19 543
Masaki Takagi Japan 14 290 0.9× 236 1.3× 78 0.7× 66 0.8× 19 0.4× 54 514
Anenisia C. Andrade Sweden 13 196 0.6× 344 1.9× 113 1.0× 51 0.6× 16 0.4× 18 527
Vanesa López‐González Spain 15 311 1.0× 264 1.5× 85 0.7× 45 0.6× 8 0.2× 24 532
Siham Chafai Elalaoui Morocco 14 158 0.5× 262 1.4× 47 0.4× 35 0.4× 12 0.3× 41 525
C Shimomura Japan 15 93 0.3× 131 0.7× 41 0.4× 89 1.1× 61 1.4× 25 533
Alice Costantini Sweden 13 263 0.8× 255 1.4× 65 0.6× 91 1.1× 12 0.3× 28 430

Countries citing papers authored by D. Sillence

Since Specialization
Citations

This map shows the geographic impact of D. Sillence's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Sillence with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Sillence more than expected).

Fields of papers citing papers by D. Sillence

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Sillence. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Sillence. The network helps show where D. Sillence may publish in the future.

Co-authorship network of co-authors of D. Sillence

This figure shows the co-authorship network connecting the top 25 collaborators of D. Sillence. A scholar is included among the top collaborators of D. Sillence based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Sillence. D. Sillence is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gray, Paul, D. Sillence, & Alyson Kakakios. (2011). Is Roifman syndrome an X‐linked ciliopathy with humoral immunodeficiency? Evidence from 2 new cases. International Journal of Immunogenetics. 38(6). 501–505. 10 indexed citations
2.
Tchan, Michel & D. Sillence. (2011). Fabry disease and Factor V Leiden: a potent vascular risk combination. Internal Medicine Journal. 41(5). 422–426. 4 indexed citations
3.
Fleming, Fergal J., Judith G. Hall, CT Cowell, et al.. (2005). Cyclic bisphosphonate therapy in osteogenesis imperfecta type V. Journal of Paediatrics and Child Health. 41(3). 147–151. 16 indexed citations
4.
Sillence, D., et al.. (2003). Desbuquois syndrome: Clinical and radiological report of the first two Chinese cases from a consanguineous family. Journal of Paediatrics and Child Health. 39(9). 707–712. 3 indexed citations
5.
Robinson, Cemre, Janet F. Noble, Alan R. King, et al.. (2003). The osteodystrophy of mucolipidosis type III and the effects of intravenous pamidronate treatment. Journal of Inherited Metabolic Disease. 25(8). 681–693. 32 indexed citations
6.
Sillence, D., et al.. (2000). Cyclic intravenous pamidronate therapy for osteogenesis imperfecta. Bone. 27(4). 27–27. 1 indexed citations
7.
Sillence, D.. (2000). Osteogenesis Imperfecta 2000. Bone. 27(4). 4–4. 4 indexed citations
8.
Sillence, D., et al.. (1997). Atelosteogenesis syndromes: a review, with comments on their pathogenesis. Pediatric Radiology. 27(5). 388–396. 24 indexed citations
9.
Ogle, Robert, Meredith Wilson, K Kozłowski, & D. Sillence. (1994). Desbuquois syndrome complicated by obstructive sleep apnoea and cervical kyphosis. American Journal of Medical Genetics. 51(3). 216–221. 9 indexed citations
10.
Sillence, D., Warick Delprado, Matthew Edwards, & K. Kozlowski. (1994). Case report 870. Skeletal Radiology. 23(7). 586–8. 2 indexed citations
11.
Ogle, Robert, et al.. (1994). X linked mental retardation with non-deletional alpha thalassaemia (ATR-X): further delineation of the phenotype.. Journal of Medical Genetics. 31(3). 245–247. 7 indexed citations
12.
Poulos, A., et al.. (1992). Ultrastructure and immunocytochemistry of hepatic peroxisomes in rhizomelic chondrodysplasia punctata. European Journal of Pediatrics. 151(11). 829–836. 17 indexed citations
13.
Beighton, Peter, A Giedion, Robert J. Gorlin, et al.. (1992). International classification of osteochondrodysplasias. European Journal of Pediatrics. 151(6). 407–415. 89 indexed citations
14.
Adès, Lesley C. & D. Sillence. (1992). Agnathia-holoprosencephaly with tetramelia. Clinical Dysmorphology. 1(3). 182???184–182???184. 7 indexed citations
15.
Beighton, Peter, Robert J. Gorlin, Judith G. Hall, et al.. (1992). International classification of osteochondrodysplasias. American Journal of Medical Genetics. 44(2). 223–229. 61 indexed citations
16.
Muller, David C., K. Kozlowski, & D. Sillence. (1992). Lethal micromelic facial bones sclerosis dysplasia. British Journal of Radiology. 65(780). 1137–1139. 2 indexed citations
17.
Bankier, Agnes, et al.. (1991). Fibrochondrogenesis in male twins at 24 weeks gestation. American Journal of Medical Genetics. 38(1). 95–98. 10 indexed citations
18.
Kozlowski, K., et al.. (1989). Dappled diaphyseal dysplasias. RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren. 150(2). 228–229. 9 indexed citations
19.
Kozlowski, K., et al.. (1987). Cloverleaf Skull and Bone Dysplasias (Report of four cases). Australasian Radiology. 31(3). 309–314. 4 indexed citations
20.
Lachman, Ralph, D. Sillence, David L. Rimoin, et al.. (1981). Diastrophic dysplasia: the death of a variant.. Radiology. 140(1). 79–86. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026